Linshuai Xu

504 total citations
16 papers, 339 citations indexed

About

Linshuai Xu is a scholar working on Rheumatology, Molecular Biology and Hematology. According to data from OpenAlex, Linshuai Xu has authored 16 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 6 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Linshuai Xu's work include Rheumatoid Arthritis Research and Therapies (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Cancer-related molecular mechanisms research (4 papers). Linshuai Xu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Cancer-related molecular mechanisms research (4 papers). Linshuai Xu collaborates with scholars based in China, United States and Hong Kong. Linshuai Xu's co-authors include Cen Chang, Lingxia Xu, Shicheng Guo, Jianan Zhao, Yiming Shi, Kai Wei, Ping Jiang, Yehua Jin, Dongyi He and Dongyi He and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Journal of Translational Medicine.

In The Last Decade

Linshuai Xu

15 papers receiving 336 citations

Peers

Linshuai Xu

RHEUM

IMMUN

NEPHR

Yiming Shi China

Yehua Jin China

Chia‐Chun Tseng Taiwan

Alice Barinotti Italy

Liu Zh China

Natalia Duque Spain

Hyun Chul Chung South Korea

Wanjun Shen China

Mel K.M. Chau Hong Kong

Yiming Shi China

Linshuai Xu

178 ×1.1

141 ×1.2

RHEUM

88 ×1.4

IMMUN

58 ×1.0

NEPHR

46 ×0.8

Citations per year, relative to Linshuai Xu Linshuai Xu (= 1×) peers Yiming Shi

Countries citing papers authored by Linshuai Xu

Since Specialization

Citations

This map shows the geographic impact of Linshuai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linshuai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linshuai Xu more than expected).

Fields of papers citing papers by Linshuai Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linshuai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linshuai Xu. The network helps show where Linshuai Xu may publish in the future.

Co-authorship network of co-authors of Linshuai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Linshuai Xu. A scholar is included among the top collaborators of Linshuai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linshuai Xu. Linshuai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jin, Yehua, Cen Chang, Xinpeng Zhou, et al.. (2024). LncRNA NONHSAT042241 inhibits rheumatoid synovial proliferation, inflammation and aggression via inactivating WNT/β-catenin signaling pathway. Autoimmunity. 57(1). 2387076–2387076. 1 indexed citations

Zhao, Jianan, Lingxia Xu, Kai Wei, et al.. (2024). Identification of clinical characteristics biomarkers for rheumatoid arthritis through targeted DNA methylation sequencing. International Immunopharmacology. 131. 111860–111860. 3 indexed citations

Zhao, Jianan, Kai Wei, Yiming Shi, et al.. (2023). Identification of immunological characterization and Anoikis-related molecular clusters in rheumatoid arthritis. Frontiers in Molecular Biosciences. 10. 1202371–1202371.

Zhao, Jianan, Mi Zhou, Kai Wei, et al.. (2023). Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application. Frontiers in Pharmacology. 14. 1306584–1306584. 8 indexed citations

Wei, Kai, Lingxia Xu, Cen Chang, et al.. (2023). DNA methylation change of HIPK3 in Chinese rheumatoid arthritis and its effect on inflammation. Frontiers in Immunology. 13. 1087279–1087279. 12 indexed citations

Zhao, Jianan, Kai Wei, Ping Jiang, et al.. (2023). A comprehensive review of Tripterygium wilfordii hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions. Frontiers in Pharmacology. 14. 1282610–1282610. 30 indexed citations

Shi, Yiming, Cen Chang, Lingxia Xu, et al.. (2023). Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis. Immunity Inflammation and Disease. 11(6). e902–e902. 9 indexed citations

Chang, Cen, Yehua Jin, Lingxia Xu, et al.. (2022). Identification of DNA methylation-regulated differentially expressed genes in RA by integrated analysis of DNA methylation and RNA-Seq data. Journal of Translational Medicine. 20(1). 481–481. 11 indexed citations

Wei, Kai, Cen Chang, Jianan Zhao, et al.. (2022). SFRP1 Negatively Modulates Pyroptosis of Fibroblast‐Like Synoviocytes in Rheumatoid Arthritis: A Review. Frontiers in Immunology. 13. 903475–903475. 17 indexed citations

10.

Zhao, Jianan, Lingxia Xu, Cen Chang, et al.. (2022). Circulating methylation level of HTR2A is associated with inflammation and disease activity in rheumatoid arthritis. Frontiers in Immunology. 13. 1054451–1054451. 13 indexed citations

11.

Zhao, Jianan, Kai Wei, Ping Jiang, et al.. (2022). G-Protein-Coupled Receptors in Rheumatoid Arthritis: Recent Insights into Mechanisms and Functional Roles. Frontiers in Immunology. 13. 907733–907733. 14 indexed citations

12.

Chang, Cen, Lingxia Xu, Runrun Zhang, et al.. (2022). MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis. Frontiers in Immunology. 13. 838884–838884. 48 indexed citations

13.

Xu, Lingxia, Cen Chang, Ping Jiang, et al.. (2022). Metabolomics in rheumatoid arthritis: Advances and review. Frontiers in Immunology. 13. 961708–961708. 60 indexed citations

14.

Wei, Kai, Jianan Zhao, Yehua Jin, et al.. (2022). Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis. Frontiers in Immunology. 13. 865267–865267. 15 indexed citations

15.

Zhao, Jianan, Kai Wei, Ping Jiang, et al.. (2022). Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications. Frontiers in Immunology. 13. 888306–888306. 64 indexed citations

16.

Zhou, Xinpeng, Duoli Xie, Jie Huang, et al.. (2021). Therapeutic Effects of (5R)-5-Hydroxytriptolide on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via lncRNA WAKMAR2/miR-4478/E2F1/p53 Axis. Frontiers in Immunology. 12. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact